64
Participants
Start Date
June 30, 2007
Primary Completion Date
August 31, 2013
Study Completion Date
September 4, 2017
Entecavir
Tablets / Oral Solution, Oral, Naïve: 0.015 mg/kg up to 0.5 mg; Experienced: 0.030 mg/kg up to 1 mg, once daily, 48 - 120 weeks depending on response
Local Institution, Taipei
Local Institution, Brussels
Local Institution, Buenos Aires
Mount Sinai School Of Medicine, New York
Children'S Hospital Of Philadelphia, Philadelphia
Johns Hopkins School Of Medicine, Baltimore
University Of Florida, Gainesville
University Of Texas Southwestern Medical Center, Dallas
Local Institution, Porto Alegre
University of California, San Francisco, San Francisco
Connecticut Children'S Medical Center, Hartford
Boston Childrens Hospital, Boston
Rhode Island Hospital, Providence
Local Institution, Sco Paulo
Local Institution, Toronto
Local Institution, Seoul
Local Institution, Seoul
Local Institution, London
Local Institution, Birmingham
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY